JPWO2021235044A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021235044A5
JPWO2021235044A5 JP2022514027A JP2022514027A JPWO2021235044A5 JP WO2021235044 A5 JPWO2021235044 A5 JP WO2021235044A5 JP 2022514027 A JP2022514027 A JP 2022514027A JP 2022514027 A JP2022514027 A JP 2022514027A JP WO2021235044 A5 JPWO2021235044 A5 JP WO2021235044A5
Authority
JP
Japan
Prior art keywords
arteriosclerosis
triglyceride
accumulating
agent according
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022514027A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021235044A1 (cg-RX-API-DMAC7.html
JP7456662B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/008689 external-priority patent/WO2021235044A1/ja
Publication of JPWO2021235044A1 publication Critical patent/JPWO2021235044A1/ja
Publication of JPWO2021235044A5 publication Critical patent/JPWO2021235044A5/ja
Priority to JP2022127299A priority Critical patent/JP2022166145A/ja
Application granted granted Critical
Publication of JP7456662B2 publication Critical patent/JP7456662B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022514027A 2020-05-22 2021-03-05 中性脂肪蓄積型動脈硬化退縮剤 Active JP7456662B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022127299A JP2022166145A (ja) 2020-05-22 2022-08-09 中性脂肪蓄積型動脈硬化退縮剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020090091 2020-05-22
JP2020090091 2020-05-22
JP2020192099 2020-11-18
JP2020192099 2020-11-18
PCT/JP2021/008689 WO2021235044A1 (ja) 2020-05-22 2021-03-05 中性脂肪蓄積型動脈硬化退縮剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022127299A Division JP2022166145A (ja) 2020-05-22 2022-08-09 中性脂肪蓄積型動脈硬化退縮剤

Publications (3)

Publication Number Publication Date
JPWO2021235044A1 JPWO2021235044A1 (cg-RX-API-DMAC7.html) 2021-11-25
JPWO2021235044A5 true JPWO2021235044A5 (cg-RX-API-DMAC7.html) 2022-05-12
JP7456662B2 JP7456662B2 (ja) 2024-03-27

Family

ID=78708421

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514027A Active JP7456662B2 (ja) 2020-05-22 2021-03-05 中性脂肪蓄積型動脈硬化退縮剤
JP2022127299A Pending JP2022166145A (ja) 2020-05-22 2022-08-09 中性脂肪蓄積型動脈硬化退縮剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022127299A Pending JP2022166145A (ja) 2020-05-22 2022-08-09 中性脂肪蓄積型動脈硬化退縮剤

Country Status (4)

Country Link
US (1) US12576061B2 (cg-RX-API-DMAC7.html)
EP (1) EP4154877A4 (cg-RX-API-DMAC7.html)
JP (2) JP7456662B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021235044A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7236119B2 (ja) * 2019-06-21 2023-03-09 学校法人近畿大学 大動脈瘤の予防用医薬組成物および加工食品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393224B2 (en) * 2011-08-26 2016-07-19 Osaka University Prophylactic and/or therapeutic agent for cardiovascular complications of diabetes

Similar Documents

Publication Publication Date Title
Dellinger Cardiovascular management of septic shock
Van Crevel et al. Clinical management of combined tuberculosis and diabetes
JP2022009125A5 (cg-RX-API-DMAC7.html)
Carpentier et al. Safety and tolerability of subcutaneous treprostinil in newborns with congenital diaphragmatic hernia and life-threatening pulmonary hypertension
Bundgaard-Nielsen et al. Orthostatic intolerance and the cardiovascular response to early postoperative mobilization
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2018172440A5 (cg-RX-API-DMAC7.html)
Cheng et al. The response to methylene blue in patients with severe hypotension during liver transplantation
Musso et al. Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature
JP2017014206A5 (cg-RX-API-DMAC7.html)
Ermolova et al. Correction of intrahepatic microcirculation disorders by L-ornithine-L-aspartate at the chronic liver diseases patients
Zhao et al. Septic shock due to community‑acquired Pseudomonas aeruginosa necrotizing fasciitis: A case report and literature review
Su et al. The current opinions of capillary leak syndrome
ECSP055914A (es) Combinación farmacéutica para la prevención o la terapia de enfermedades cardiovasculares, cardiopulmonares, pulmonares o renales
Mathur et al. Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography
Yanase et al. A comparison of the hemodynamic effects of fluid bolus therapy with crystalloids vs. 4% albumin and vs. 20% albumin in patients after cardiac surgery
JP2023060011A5 (cg-RX-API-DMAC7.html)
Karnad et al. Continuous renal replacement therapy may aid recovery after cardiac arrest
JP2018523711A5 (cg-RX-API-DMAC7.html)
JPWO2020166557A5 (cg-RX-API-DMAC7.html)
Wilhelm Epidural anesthesia for cesarean delivery facilitated by minimally invasive hemodynamic monitoring in a patient with Fontan repair: a case report.
Kurhekar et al. Myocardial stunning after resuscitation from cardiac arrest following spinal anaesthesia
Kogelmann et al. Successful treatment with Cytosorb in a case of septic shock, ARDS, multiorgan failure and pur-pura fulminans due to Acinetobacter baumannii pneumonia
Nur et al. PHARMACEUTICAL MARKET IN MALAYSIA
Artikova et al. PROBLEMS IN THE TREATMENT OF HYPERTENSION AND METHODS OF THEIR ELIMINATION